• Users Online: 1217
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 15  |  Issue : 2  |  Page : 255-260

Immunohistochemical expression of p63 in oral premalignant disorders and its correlation with oral squamous cell carcinoma


1 Department of Oral and Maxillofacial Pathology, Krishnadevaraya College of Dental College and Hospital, Sir MVIT Campus, Bengaluru, Karnataka, India
2 Department of Oral Pathology, Government Dental College and Hospital, Hyderabad, Telangana, India

Correspondence Address:
Dr. K Paremala
Department of Oral Pathology, Government Dental College and Hospital, Hyderabad - 500 012, Telangana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/jdmimsu.jdmimsu_26_20

Rights and Permissions

Introduction: Oral squamous cell carcinoma (OSCC) represents 95% of all head and neck cancers, and its incidence has increased by 50% in the past decade. Accumulation of genetic alterations (mutations, loss of heterozygosity, loss or gain of chromosomes) is the basis for the progression from a normal cell to a cancer cell. OSCCs are frequently preceded by oral potentially malignant disorders (PMDs). It is difficult to predict the malignant transformation of these PMDs. Thus, early detection of genetic changes in PMDs can facilitate detection of those lesions, which may have potential to progress to malignancy. p63 is a protein coded by p63 gene which is a homolog of p53 gene. It has a critical role in cell cycle regulation and is associated with epithelial tumorigenesis. The present study aims to evaluate the role of p63 in carcinogenesis in PMDs (Leukoplakia, Oral submucous fibrosis and Lichen planus) and OSCCs using immunohistochemistry. Aims and Objectives: The aim is to evaluate the expression of the p63 IHC marker in oral premalignant disorders and to compare its expression in OSCC. Materials and Methods: Tissue sections of PMDs (105 cases) and OSCCs (35 cases) were stained for IHC marker p63. The percentage of positive cells and staining patterns were assessed for all the lesions. Results and Conclusions: Progressive accumulation of p63-immunopositive cells from PMDs to OSCC reflects its major role in the development of OSCC according to a multiple-stage model of carcinogenesis and can be a useful indicator of dysplastic change, thus serving as a biomarker for cancer progression.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed144    
    Printed12    
    Emailed0    
    PDF Downloaded15    
    Comments [Add]    

Recommend this journal